Pattern of Recurrence After Platinum-Containing Definitive Therapy and Efficacy of Salvage Treatment for Recurrence in Patients with Squamous Cell Carcinoma of the Head and Neck

BACKGROUND: In first-line systemic therapy for unresectable recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), regimens are generally selected by time-to-relapse with 6 months cutoff after platinum (Pt)-containing definitive therapy, Pt-refractory or Pt-sensitive r...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakasugi, Tetsuro, Nguyen, Thi Nga, Takeuchi, Shoko, Ohkubo, Jun-ichi, Suzuki, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289148/
https://www.ncbi.nlm.nih.gov/pubmed/35860589
http://dx.doi.org/10.3389/fonc.2022.876193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289148/
https://www.ncbi.nlm.nih.gov/pubmed/35860589
http://dx.doi.org/10.3389/fonc.2022.876193

Ejemplares similares